Phase 2 Study of Apixaban Reversal by Ciraparantag as Measured by WBCT

NCT03288454 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Ciraparantag
DRUG: Placebo
DRUG: Apixaban

Sponsor

Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc.